Rimon
Save as PDF RSS Feed Subscribe

Entries tagged “Technology”

The FDA Drug Approval Process in the Lifecycle of a Pre-Sales Revenue Biotechnology Venture Destined for IPO Success

Insight Mark H. Mirkin Mark H. Mirkin · February 25, 2014
The U.S. Food & Drug Administration regulates new drug approvals in a process that is extremely thorough, lengthy and expensive. Regulations apply to a drug candidate’s product development phase, the approval process and after approval. Failure to comply could have serious business and financial con-sequences to a biotech venture,

Continue Reading…

Tech Transfers in the Lifecycle of a Pre-Sales Revenue Biotechnology Venture Destined for IPO Success

Insight Mark H. Mirkin Mark H. Mirkin · February 19, 2014
Many biotech ventures begin life as an invention conceived by a scientist/professor working in a laboratory at a federally-funded university or scientific institute. The intellectual property underlying such inventions is owned by the academic institution, a potentially valuable asset to be nurtured. Since enactment of the Bayh-Dole Act in 1980,

Continue Reading…

Trolls, Wizards, and the Pitfalls of Patenting

Insight May 08, 2012

Patents are back in the news. In the past few weeks alone, Microsoft bought AOL’s patent portfolio for $1 billion, then resold much of it to Facebook for $550 million. Twitter pledged to use its patents only defensively, and to give its employee-inventors a say in the company’s future patent litigation strategy. Controversial trials, appeals, rulings, and awards continue—prompting the Wall Street Journal to publish Andy Kessler’s call for curtailing the rights of non-practicing entities (NPEs), also known affectionately as “trolls.” 

Continue Reading…

2011 America Invents Act:  How will the patent reforms impact startups?

Insight October 19, 2011

After several sporadic decisions issued by the Supreme Court impacting the US patent system and years of debate about how the system should be improved, Congress recently passed the Leahy-Smith America Invents Act (HR 1249).  President Obama signed the Act into law on September 16, 2011.  The text of the Act can be found here.

The provisions of the new law have a variety of effective dates.  Some of the changes take effect immediately.  Fee increases will be instituted on September 26, 2011.  Other changes will not be implemented until 2012 and 2013.

Continue Reading…

What do Tech Investors Want?

Insight August 22, 2011

Last week, Google announced its plans to acquire Motorola Mobility, effecting a vertical integration from the Android operating system into hardware.  Investors responded by shaving roughly 13% off Google’s value—roughly twice as much as the NASDAQ lost and three times as much as the Dow.

information age11

Continue Reading…

Twitter to Stay in San Francisco: Future Tax Breaks for Tech Companies?

Insight June 03, 2011

Recently, the San Francisco Board of Supervisors voted to give Twitter a 6 year break from the city’s 1.5% payroll tax – which also extends to stock options – to prevent them from leaving, losing their tax revenues, and to promote job creation in the city. 

Continue Reading…

Clean Tech Companies in Obama’s Administration

Insight Michael Moradzadeh Michael Moradzadeh · August 28, 2009

Clean Tech is generally considered to include multiple advanced technologies in four economic sectors: energy, waste, materials, and transportation. These technologies break down in categories such as energy generation and storage, water and wastewater, air and environment, etc. There is no clear-cut definition for a “Clean-Tech” Company, but as shown by its name, a clean-tech company should be a company equipping its core business with clean technology. As a related concept, Clean-tech Law contemplates a diverse set of legal issues related to the commercialization of clean technology, and the more traditional legal areas of clean technology law include intellectual property, patent law, licensing, litigation, and federal state legislative and regulatory issues.

Continue Reading…